[Sustained monomorphic ventricular tachycardia in non ischemic heart diseases].
Sustained ventricular tachycardia in the absence of coronary artery disease is mainly observed in diffuse left ventricular cardiomyopathy especially dilated but sometimes hypertrophic, and in right sided cardiomyopathies such as ventricular dysplasia, more difficult to diagnose. More rarely, other localised abnormalities, mitral valve prolapse, cardiac tumour and idiopathic aneurysm, may give rise to this arrhythmia. Irrespective of the case, sustained ventricular tachycardia carries a poor prognosis during the most advanced stages of a myocardial disease. The therapeutic strategy remains the same as that of other cases of sustained ventricular tachycardia, drug therapy generally orientated by the results of programmed ventricular stimulation with the exception of Class I antiarrhythmics when the ejection fraction is under 30%, and non-pharmacological methods when drug therapy fails.
Frank
R
R
Unité de rythmologie, hôpital Jean-Rostand, Ivry-sur-Seine.
Lascault
G
G
Tonet
J
J
Aouate
P
P
Fontaine
G
G
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000150:complications*; D017147:Defibrillators, Implantable; D005260:Female; D006352:Heart Ventricles / Q000002:abnormalities*; D006801:Humans; D008297:Male; D008945:Mitral Valve Prolapse / Q000150:complications*; D011379:Prognosis; D013318:Stroke Volume; D017180:Tachycardia, Ventricular / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D016278:Ventricular Function, Right
D000889:Anti-Arrhythmia Agents
Les tachycardies ventriculaires soutenues monomorphes des cardiopathies non ischémiques.